San Marcos, TX4 Active Studies

Ankylosing Spondylitis Clinical Trials in San Marcos, TX

Find 4 actively recruiting ankylosing spondylitis clinical trials in San Marcos, TX. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,800
Enrolling

Recruiting Ankylosing Spondylitis Studies in San Marcos

RecruitingSan Marcos, TXNCT06709014

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main q...

760 participants
Annovis Bio Inc.
View Study Details
RecruitingSan Marcos, TXNCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

This study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a CDK4/6i and letrozole i...

450 participants
Hoffmann-La Roche
View Study Details
RecruitingSan Marcos, TXNCT05511363

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the st...

380 participants
Karuna Therapeutics
View Study Details
RecruitingSan Marcos, TXNCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately...

210 participants
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
View Study Details

About Ankylosing Spondylitis Clinical Trials in San Marcos

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in San Marcos, TX. These studies are seeking a combined 1,800 participants. Research is being sponsored by Annovis Bio Inc., Hoffmann-La Roche, Karuna Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in San Marcos — FAQ

Are there ankylosing spondylitis clinical trials in San Marcos?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in San Marcos, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Marcos?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Marcos research site will contact you about next steps.

Are clinical trials in San Marcos free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Marcos studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in San Marcos are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov